See-Mode vs. Imorgon

See-Mode Technologies is a MedTech company dedicated to leveraging artificial intelligence to improve ultrasound reporting, thereby enhancing both the precision of diagnoses and the efficiency of operations. Their groundbreaking platform quickly analyzes ultrasound images related to the thyroid and breast, leading to swift and accurate radiology reports. By effectively identifying, measuring, and characterizing nodules, See-Mode generates a detailed TI-RADS sonographer worksheet along with preliminary assessments for radiologists. In the sphere of breast imaging, the application not only identifies lesions but also automates the BI-RADS reporting procedure, providing in-depth information regarding lesion characteristics and levels of suspicion. This sophisticated technology reduces variability between operators and diminishes the chances of reporting mistakes, which in turn boosts diagnostic confidence and ensures uniformity in results. By optimizing the reporting workflow, See-Mode empowers clinicians to make better-informed decisions, ultimately contributing to improved patient outcomes. This comprehensive approach marks a significant advancement in the field of medical imaging technology.

Significantly improve the speed and quality of Radiology reporting by reducing unnecessary dictation, particularly for ultrasound and DEXA. Imorgon transfers modality measurements into Powerscribe/Fluency/RadAI merge fields/tokens, eliminating manual entry errors. Imorgon's specialized services offer the following advantages: - All measurements are always transferred (usually DICOM SR) - Electronic worksheets capture findings and insert them into Powerscribe/Fluency/RadAI (rather than dictating from a worksheet) - Worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc) - Integrate into Epic or other EHRs - Vendor neutral - Support to ensure everything continues working Significant improvement in the overhead of reporting with a quick ROI.